Antigen-induced regulatory T cells in autoimmunity

Nature Reviews Immunology

Volumn 3, Issue 3, 2003, Pages 223-232

  Von Herrath, Matthias G ^a   Harrison, Leonard C ^b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIGEN; COLLAGEN; INSULIN; MYELIN BASIC PROTEIN; RETINA S ANTIGEN; THYROGLOBULIN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; AUTOIMMUNITY; CLINICAL TRIAL; HASHIMOTO DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; T LYMPHOCYTE; TISSUE INJURY; UVEITIS; ANIMAL; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; IMMUNOLOGY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 0037361819     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1029     Document Type: Review

References (124)

1. Ashton-Rickardt, P. G. et al. Evidence for a differential avidity model of T-cell selection in the thymus. Cell 76, 651-663 (1994).
2. Klein, L., Klugmann, M., Nave, K. A., Tuohy, V. K. & Kyewski, B. Shaping of the autoreactive T-cell repertoire by a splice variant of self-protein expressed in thymic epithelial cells. Nature Med. 6, 56-61 (2000).
3. Heath, V. L., Moore, N. C., Parnell, S. M. & Mason, D. W. Intrathymic expression of genes involved in organ-specific autoimmune disease. J. Autoimmun. 11, 300-318 (1998).
4. Burns, J., Rosenzweig, A., Zweiman, B. & Lisak, R. P. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell. Immunol. 81, 435-440 (1983).
5. Arnold, B., Schonrich, G. & Hammerling, G. J. Multiple levels of peripheral tolerance. Immunol. Today 14, 12-14 (1993).
6. Saoudi, A., Seddon, B., Heath, V., Fowell, D. & Mason, D. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T-cell subset. Immunol. Rev. 149, 195-216 (1996).
7. Zinkernagel, R. M. Localization, dose and time of antigens determine immune reactivity. Semin. Immunol. 12, 163-171 (2000).
8. Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998).
9. Dooms, H. & Abbas, A. K. Life and death in effector T cells. Nature Immunol. 3, 797-798 (2002).
10. Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M. & Feldman, M. Induction of tolerance in influenza virus-immune T-lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157, 1434-1447 (1983).
11. Quill, H. & Schwartz, R. H. Stimulation of normal inducer T-cell clones with antigen presented by purified la molecules in planar lipid membranes: specific induction of a long-lived state of proliferative non-responsiveness. J. Immunol. 138, 3704-3709 (1987).
12. Sloan-Lancaster, J., Evavold, B. D. & Allen, P. M. Induction of T-cell anergy by altered T-cell receptor ligand on live antigen-prasenting cells. Nature 363, 156-159 (1993).
13. Powell, J. D., Lerner C. G. & Schwartz, R. H. Inhibition of cell-cycle progression by rapamycin induces T-cell clonal anergy even in the presence of costimulation. J. Immunol. 162, 2775-2784 (1999).
14. + T cells. J. Exp. Med. 184, 19-29 (1996).
15. + T-cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 163, 3684-3691 (1999).
16. Lechler, R., Chai, J.-G., Marelli-Berg, F. & Lombardi, G. The contributions of T-cell energy to peripheral T-cell tolerance. Immunology 103, 262-269 (2001).
17. Sayegh, M. H., Khoury, S. J., Hancock, W. W., Weiner, H. L. & Carpenter C. B. Mechanisms of oral tolerance by MHC peptides. Ann. NY Acad. Sci. 778, 338-345 (1996).
18. Millar, A., al-Sabbagh, A., Santos, L. M., Das, M. P. & Weiner, H. L. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151, 7307-7315 (1993).
19. H2 paradigm in immunity to infectious diseases. Trends Immunol. 9, 450-455 (2002).
20. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212-1218 (1998).
21. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135-142 (2002).
22. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
23. Gershon, R. K. & Kondo, K. Infectious immunological tolerance. Immunology 21, 903-914 (1971).
24. Hall, B. M., Jelbart, M. E., Gudey, K. E. & Dorsch, S. E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J. Exp. Med. 162, 1683-1694 (1985).
25. + suppressor cell and its mechanisms of action. J. Exp. Med. 171, 141-157 (1990).
26. Qin, S. X. et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20, 2737-2745 (1990).
27. Qin, S. et al. 'Infectious' transplantation tolerance. Science 259, 974-977 (1993).
28. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 16, 311-323 (2002).
29. Kawaguchi-Miyashita, M. et al. Development and cytolytic function of intestinal intraepithelial lymphocytes in antigen-minimized mice. Immunology 89, 268-273 (1996).
30. Waldmann, H. Reprogramming the immune system. Immunol. Rev. 185, 227-235 (2002).
31. Hong, S. et al. The natural killer T-cell lligand α -galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052-1056 (2001).
32. + regulatory T cells by oral antigen administration. J. Immunol. 167, 4245-4253 (2001).
33. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167, 188-195 (2001).
34. Harrison, L. C. & Hafler, D. A. Antigen-specific therapy for autoimmune disease. Curr. Opin. Immunol. 12, 704-711 (2000).
35. Faria, A. M. & Weiner, H. L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73, 153-264 (1999).
36. Hanninen, A. & Harrison, L. C. γδ T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173, 109-119 (2000).
37. Harnson, L. C., Dempsey-Collier, M., Kramer, D. R. & Takahashi, K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184, 2167-2174 (1996).
38. Matzinger, P. Tolerance, danger and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
39. + immunoregulatory T cells: gene-expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
40. Sundstedt, A., O'Neill, E. J., Nicolson, K. S. & Wraith, D. C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 110, 1240-1248 (2003).
41. Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-920 (2002).
42. Zelenika, D. et al. Regulatory T cells overexpress a subset of T_2 gene transcripts. J. Immunol. 168, 1069-1079 (2002).
43. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
44. + suppressor T cells in vivo. Nature Immunol. 3, 33-41 (2002).
45. Bach, J. F. Regulatory T cells under scrutiny. Nature Rev. Immunol. 3, 189-198 (2003).
46. Kassiotis, G., Garcia, S., Simpson, E. & Stockinger, B. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nature immunol. 3, 244-250 (2002). References 45 and 46 highlight the issue that regulation might occur as a function of competition for space in immunodeficient hosts, which should be taken into account when interpreting data from the transfer of T cells into irradiated or SCID mice.
47. Reg cells depends on IL-4 and STAT6. Such cells are induced by oral administration of insulin B-chain and they locally suppress aggressive lymphocytes in the pancreatic draining lymph nodes, thereby preventing diabetes.
48. Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
49. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol. 3, 756-763 (2002).
50. + T cells that prevent spontaneous autoimmune encephalomyelitis. J. Immunol. 164, 5499-5507 (2000).
51. + subpopulations. J. Immunol. 165, 3105-3110 (2000).
52. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
53. + suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389-400 (2002).
54. nigh regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253 (2001).
55. + regulatory T cells. Proc. Natl Acad Sci. USA 99, 13031-13036 (2002).
56. + T cells. J. Immunol. 169, 3232-3241 (2002).
57. Trinchieri, G. Regulatory role of T cells producing both interferon-γ and interleukin-10 in persistent infection. J. Exp. Med. 194, F53-F57 (2001).
58. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507 (2002).
59. Reg cells in controlling the immunopathology of infectious disease.
60. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164, 240-247 (2000).
61. Boitard, C., Yasunami, R., Dardenne, M. & Bech, J. F. T-cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169, 1669-1680 (1989).
62. Bach, J. F. Immunotherapy of insulin-dependent diabetes mellitus. Curr. Opin. Immunol. 13, 601-605 (2001).
63. Martinez, N. R. & Harrison, L. C. Disabling a constitutive CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. (in the press).
64. H3 regulatory cells. Immunol. Rev. 182, 207-214 (2001).
65. + regulatory T cells in vivo in humans. Blood 100, 174-177 (2002).
66. Viney J. L., Mowat, A. M., O'Malley, J. M., Williamson, E. & Fanger, N. A. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160, 5815-5825 (1998).
67. + T cells from glutamic acid decarboxylase (GAD)65-specific T-cell receptor-transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196, 481-492 (2002).
68. + regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301-306 (2001).
69. H3 regulatory cells. Nature Immunol. 2, 671-672 (2001).
70. Mayrhofer, G. & Schon-Hegrad, M. A. La antigens in rat kidney, with special reference to their expression in tubular epithelium. J. Exp. Med. 157, 2097-2109 (1983).
71. Mayer, L. & Shlien, R. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166, 1471-1483 (1987).
72. + T cells. Eur. J. Immunol. 19, 1513-1516 (1989).
73. Massey, E. J. et al. Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T-cell function within the context of experimental autoimmune encephalomyelitis. Vet. Immunol. Immunopathol. 87, 357-372 (2002).
74. Anderton, S. M. & Wraith, D. C. Selection and fine-tuning of the autoimmune T-cell repertoire. Nature Rev. Immunol. 2, 487-498 (2002).
75. + T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 7, 655-663 (1994).
76. Zang, J. A., Davidson, L., Elsenbarth, G. & Weiner, H. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl Acad. Sci. USA 88, 10252-10256 (1991).
77. Daniel, D. & Wegmann, D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl Acad. Sci. USA 93, 956-960 (1996).
78. Martinez, N. R. et al. Disabling a constitutive CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. (in the press).
79. Harrison, L. C. et al. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J. Exp. Med. 185, 1013-1021 (1997).
80. Pozzilli, P., Signore, A., Williams, A. J. & Beales, P. E. NOD mouse colonies around the world - recent facts and figures. Immunol. Today 14, 193-196 (1993).
81. Suzuki, T. in immune-Deficient Animals in Biomedical Research (eds Rygaard, J., Brunner, N., Graem, N. & Spang-Thomsen, M.) 112-116 (Karger, Basel, 1987).
82. Imaoka, A., Matsumoto, S., Setoyama, H., Okada, Y. & Umesaki, Y. Proliferative recruitment of intestinal intraepithelial lymphocytes after microbial colonization of germ-free mice. Eur. J. Immunol. 26, 945-948 (1996).
83. Mengel, J. et al. Anti-γδ T-cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 48, 97-102 (1995).
84. Ke, Y., Pearce, K., Lake, J. P., Ziegler, H. K. & Kapp, J. A. γδ T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 158, 3610-3618 (1997).
85. Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T-cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994).
86. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160, 4719-4729 (1998).
87. Weaver, D. J. Jr, Liu, B. & Tisch, R. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 586-592 (2001).
88. Coon, B., An, L. L., Whitton, J. L. & von Herrath, M. G. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104, 189-194 (1999).
89. Bot, A. et al. Plasmid vaccination with insulin B-chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 2950-2955 (2001).
90. Wolfe, T. et al. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety. Eur. J. Immunol. 32, 113-121 (2002).
91. H2 cytokines and prevent disease of the central nervous system. Importantly, the addition of cytokines such as IL-4 enhanced the efficacy of this approach.
92. Liu, E. et al. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B: 13-23. J. Clin. Invest. 110, 1021-1027 (2002).
93. Weiner, H. L. et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259, 1321-1324 (1993).
94. Levings, M. K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530-5539 (2001).
95. Van Regenmortel, M. H. V. Synthetic peptides help in diagnosing viral infections. ASM News 64, 332 (1998).
96. + regulatory T cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T cells. Diabetes 48, 1720-1729 (1999).
97. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097-1101 (2002).
98. Munn, D. H. et al. Potential regulatory function of human dendntic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870 (2002). References 97 and 98 show a new mechanism by which antigen-presenting cells can induce tolerance in their local microenvironment by depleting tryptophane. CTLA4 and IFN-γ can induce the expression of IDO, which catabolizes tryptophane and mediates tolerance.
99. Steinman, R. M. & Nussenzweig, M. C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T-cell tolerance. Proc. Natl Acad. Sci. USA 99, 351-358 (2002).
100. - dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099-1104 (2002).
101. Guillot, C. et al. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood 19 December 2002 (DOI: 10.1182/blood-2002-07·2076).
102. Homann, D. et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16, 403-415 (2002).
103. Tompkins, S. M., Fuller, K. G. & Miller, S. D. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann. NY Acad. Sci. 958, 26-38 (2002).
104. von Herrath, M., Coon, B. & Wolfe, T. Tolerance induction with agonist peptides recognized by autoaggressive lymphocytes is transient: therapeutic potential for type 1 diabetes is limited and depends on time-point of administration, choice of epitope and adjuvant. J. Autoimmun. 16, 193-199 (2001).
105. Trentham, D. E. et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727-1730 (1993).
106. Thurau, S. R., Diedrichs-Mohring, M., Fricke, H., Arbogast, S. & Wildner, G. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis patients with an MHC-peptide crossreactive with autoantigen - first results. Immunol. Lett. 57, 193-201 (1997).
107. Lee, S., Scherberg, N. & DeGroot, L. J. Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 8, 229-234 (1998).
108. Pozzilli, P. et al. No effect of oral insulin on residual β-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 43, 1000-1004 (2000).
109. Chaillous, L. et al. Oral insulin administration and residual β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabete Insuline Orale group. Lancet 356, 545-549 (2000).
110. H3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70-77 (1996).
111. Hanninen, A., Braakhuis, A., Heath, W. R. & Harrison, L. C. Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes 50, 771-775 (2001).
112. Hanninen, A., Martinez, N. R., Davey, G. M., Heath, W. R. & Harrison, L. C. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J. Clin. Invest. 109, 261-267 (2002). Mucosal administration of antigen is a 'double-edged sword' because of the potential to induce autoaggressive T cells as well as tolerance. This study shows that co-induction of autoaggressive T cells can be prevented by transient co-stimulation blockade. It has important implications for enhancing the efficacy and safety of antigen-specific tolerance in clinical trials.
113. Metzler, B. & Wraith, D. C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159-1165 (1993).
114. Homann, D., Dyrberh, T., Petersen, J., Oldstone, M. B. & von Herrath, M. G. Insulin in oral immune 'tolerance': a one-amino acid change in the B chain makes the difference. J. Immunol. 163, 1833-1888 (1999).
115. Waldo, F. B., van den Wall Bake, A. W., Mestecky, J. & Husby, S. Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 72, 30-34 (1994).
116. Genain, C. P. et al. Late complications of immune deviation therapy in a nonhuman primate. Science 274, 2054-2057 (1996).
117. Eisenbarth, G. S. & Kotzin, B. L. Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction. J. Clin. Invest 111, 179-181 (2003).
118. Reijonen, H. et al. Detection of GAD65-specific T cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51, 1375-1382 (2002).
119. Herold, K. C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698 (2002).
120. + regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β. Cancer Res. 62, 5267-5272 (2002).
121. Kumar, V. & Sercarz, E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J. Immunol. 161, 6585-6591 (1998).
122. Zhang, Z. Y. & Michael, J. G. Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J. Immunol. 144, 4163-4165 (1990).
123. Gilliet, M. & Liu, Y.-J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695-704 (2002).
124. Rissoan, M. C. et al. Reciprocal control of T-helper cell and denddtic-cell differentiation. Science 283, 1183-1186 (1999).